What is Qulipta and What is it Used For?

Qulipta (atogepant) is a prescription medication approved by the FDA for the preventive treatment of episodic migraine in adults. It belongs to a class of drugs called CGRP receptor antagonists, which work by blocking calcitonin gene-related peptide (CGRP) receptors in the brain that are involved in migraine pathways.

Unlike acute migraine treatments that are taken during a migraine attack, Qulipta is designed to be taken daily to help reduce the frequency of migraine episodes before they occur. The medication is available as oral tablets in different strengths and is typically prescribed for adults who experience episodic migraines.

Qulipta works by targeting CGRP, a protein that plays a key role in migraine development. By blocking CGRP receptors, the medication may help prevent the cascade of events that lead to migraine attacks. Clinical studies have demonstrated its effectiveness in reducing monthly migraine days compared to placebo.

Patients considering Qulipta should discuss their complete medical history with their healthcare provider, as the medication may not be suitable for everyone. Like all prescription medications, Qulipta can cause side effects, and patients should be aware of potential interactions with other medications they may be taking.